Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Pluristem Heads for Two-Month High on $3.2 Million Israeli Grant

Pluristem Therapeutics Inc. headed for the highest close in more than two months after the developer of cell-therapy products said it received a grant of 11.8 million shekels ($3.2 million) from the Israeli government.

The shares advanced 2.2 percent to 9.38 shekels at 2:20 p.m. in Tel Aviv, poised for the highest close since Feb. 22. The shares have advanced 12.4 percent this month, trimming this year’s drop to 1.1 percent.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.